Hot Features
PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based ... PRF Technologies Ltd., a specialty pharmaceutical company, focuses on reformulation of established therapeutics in Israel. It develops OcuRing-K, a bio-erodible sustained-release implant applied to the haptic of an intraocular lens for use in cataract surgery; and PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. The company was formerly known as PainReform Ltd. and changed its name to PRF Technologies Ltd. in January 2026. PRF Technologies Ltd. was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.05 | -3.6231884058 | 1.38 | 1.45 | 1.23 | 200543 | 1.34864709 | CS |
| 4 | -0.11 | -7.63888888889 | 1.44 | 3.94 | 1.23 | 3826993 | 2.21248371 | CS |
| 12 | -1.31 | -49.6212121212 | 2.64 | 5.39 | 1.23 | 2639369 | 2.40241163 | CS |
| 26 | 0.49 | 58.3333333333 | 0.84 | 5.39 | 0.5821 | 2305175 | 2.0154126 | CS |
| 52 | 0.08 | 6.4 | 1.25 | 5.39 | 0.5821 | 1946289 | 2.07809807 | CS |
| 156 | -2.73 | -67.2413793103 | 4.06 | 26.41 | 0.1959 | 1549501 | 3.24001196 | CS |
| 260 | -1.51 | -53.1690140845 | 2.84 | 26.41 | 0.1959 | 1067863 | 3.1839741 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.